ArticleThe Canadian journal of hospital pharmacy
Drug Shortages in Canada and Selected European Countries: A Cross-Sectional, Institution-Level Comparison.
Article in The Canadian journal of hospital pharmacy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Can a national storage obligation for medicines prevent shortages? Evidence from the Finnish experience.Exploratory research in clinical and social pharmacy · 2025Article
- Perceptions, attitudes and experiences of hospital pharmacists working in the private sector regarding drug shortage in Lebanon: a national cross-sectional study.Journal of pharmaceutical policy and practice · 2025Article
- Impact of medicine shortages on hospital practice: role of a multidisciplinary medicine shortages team.International journal of clinical pharmacy · 2024Article
- Medicine shortages in France: a 6-year retrospective study in a university medical centre.European journal of hospital pharmacy : science and practice · 2023Article
- Shortages of Medicines to Treat COVID-19 Symptoms during the First Wave and Fourth Wave: Analysis of Notifications Reported to Registers in Austria, Italy, and Spain.Pharmacy (Basel, Switzerland) · 2023Article
- Prevention and management of health products shortages by the French national agency (ANSM), 10 years of experience.Frontiers in public health · 2023Article
- National and transnational drug shortages: a quantitative descriptive study of public registers in Europe and the USA.BMC health services research · 2022Article
- Proposal for Handling of Medicine Shortages Based on a Comparison of Retrospective Risk Analysis.International journal of environmental research and public health · 2022Review
- Article
- Drug Shortage: Causes, Impact, and Mitigation Strategies.Frontiers in pharmacology · 2021Review
- Article
- How to address medicines shortages: Findings from a cross-sectional study of 24 countries.Health policy (Amsterdam, Netherlands) · 2020Article
- Therapeutic alternatives and strategies for drug conservation in the intensive care unit during times of drug shortage: a report of the Ontario COVID-19 ICU Drug Task Force.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2020Article
- Drug Shortages: More than Just Background Noise.The Canadian journal of hospital pharmacyArticle
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDrug shortages represent a complex global problem affecting patients and health care professionals on a daily basis.
objectivesTo identify, describe, and compare drug shortages in health care facilities in Canada and 4 European countries in early 2018.
methodsA descriptive cross-sectional study was conducted in 1 hospital in each of 5 countries: Canada, France, Belgium, Spain, and Switzerland. Over a 4-week period, shortage data were collected daily by each hospital using a standardized grid and a standard process.
resultsFrom January 8 to February 2, 2018, there were a total of 84 shortages (median duration 32 days) in the Canadian hospital, 62 shortages (median duration 9 days) in the French hospital, 46 shortages (median duration 37 days) in the Belgian hospital, 28 shortages (median duration 25 days) in the Spanish hospital, and 98 shortages (median duration 68 days) in the Swiss hospital. The number of manufacturers implicated in the shortages was 28 for the Canadian hospital, 30 for the French hospital, 19 for the Belgian hospital, 16 for the Spanish hospital, and 42 for the Swiss hospital. Most of the shortages involved parenteral drugs, with both innovative and generic manufacturers being affected. Most therapeutic classes were affected by shortages to some extent, with the top 3 classes being anti-infective agents (accounting for 21.1% of shortages overall), central nervous system drugs (11.3%), and cardiovascular drugs (8.2%).
conclusionsDrug shortages occurred almost daily in all of the study hospitals. Across the 5 hospitals, the frequency of shortages varied by a factor of 3, which may imply similar variability at the national level. All stakeholders should work more diligently to prevent and manage drug shortages.
Indexed as
Identifiers
30828089PMC6391245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.